Skip to main content
. 2022 Feb 18;27(4):1406. doi: 10.3390/molecules27041406

Table 3.

Composition of bioactive fractions expressed as % of the total weight (i.e., g/100 g sample).

Extract Fraction Peak 1 a Peak 2 Peak 3 Peak 4 Total
Yield b
CT50 F14 1.64 9.72 15.91 3.52 30.79
F15 2.85 14.62 21.07 4.07 42.62
F16 2.89 12.52 16.32 3.51 35.24
F17 0.79 3.81 5.87 1.10 11.56
F18 1.87 8.93 14.32 2.66 27.78
F19 1.34 5.92 9.24 1.86 18.35
F20 0.20 1.10 1.75 0.34 3.40
F21 0.40 1.68 2.35 0.52 4.95
F22 1.64 9.72 15.91 3.52 30.79
CM50 F16 1.21 11.34 20.73 1.99 35.27
F17 2.42 20.48 21.16 2.83 46.89
F18 1.60 11.47 15.43 1.88 30.37
F19 1.31 9.06 10.69 1.44 22.50
F20 0.67 5.28 5.29 0.72 11.96
F21 0.49 3.34 4.23 0.58 8.64
F22 1.25 9.93 10.04 1.45 22.67
F23 0.68 5.50 4.79 0.73 11.70
F24 0.36 2.32 2.22 0.35 5.25

a 1: Igalan ([114]; not unequivocally confirmed by 1H NMR (proton nuclear magnetic resonance) due to substantial amounts of lipids in the subfraction); 2: Isoalantolactone (confirmed with standard); 3: Alantolactone (confirmed with standard); 4: unseparated mixture of dugesialactone and alloalantolactone ([114] alloalantolactone presence confirmed by 1H NMR). b Except for the eudesmanolides, fatty acids and, as it was shown by 1H NMR analysis, complex mixture of lipids without UV/Vis absorption may constitute the sample.